Sunday, February 07, 2021 6:47:48 PM
cash and cash equivalents have dropped by about $5million in both Q3 and Q4. KRMD will have to do some belt tightening, right sizing (use whatever euphemism that works for you).
Here is why the company is in a difficult situation. The former CEO "resigned" suddenly with no resignation letter. The company blaming him for all the problems does not sit well with me, because, in doing so, the management/board is failing to assume its share of ownership of the problems. And for the management/board to assume ownership of the problems might complicate things legally.
I think the best thing the management/board can do, is to assume a stance of being proactive, by initiating a rigorous internal investigation (perhaps directed by outside consultants?) to strengthen internal monitoring/control systems
Here is why the company is in a difficult situation. The former CEO "resigned" suddenly with no resignation letter. The company blaming him for all the problems does not sit well with me, because, in doing so, the management/board is failing to assume its share of ownership of the problems. And for the management/board to assume ownership of the problems might complicate things legally.
I think the best thing the management/board can do, is to assume a stance of being proactive, by initiating a rigorous internal investigation (perhaps directed by outside consultants?) to strengthen internal monitoring/control systems
Recent KRMD News
- KORU Medical Systems Presents Real World Data on the Benefits of the FreedomEDGE Syringe Infusion System in Infusion Clinics at the 51st Annual Oncology Nursing Society Congress • Business Wire • 05/18/2026 08:05:00 PM
- KORU Medical Systems Announces First Quarter 2026 Results • Business Wire • 05/06/2026 08:05:00 PM
- KORU Medical Systems to Report First Quarter 2026 Financial Results on May 6, 2026 • Business Wire • 04/16/2026 12:00:00 PM
- KORU Medical Systems Announces EU MDR Certification for the Freedom60® Infusion Pump With Prefilled Syringe Compatibility • Business Wire • 03/13/2026 12:00:00 PM
- KORU Medical Systems Announces CEO Transition • Business Wire • 03/12/2026 08:08:00 PM
- KORU Medical Systems Announces +20% Fourth Quarter and Full Year 2025 Revenue Growth, Positive Adjusted EBITDA and Initiates Full Year 2026 Guidance • Business Wire • 03/12/2026 08:05:00 PM
- KORU Medical Systems to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026 • Business Wire • 02/26/2026 09:05:00 PM
- KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO® (rozanolixizumab-noli), Expanding Label for FreedomEDGE® Infusion System • Business Wire • 01/29/2026 09:05:00 PM
- KORU Medical Systems Reports Preliminary Q4 and Full Year 2025 Results; Achieves Record Revenue and Full Year Positive Operating Cash Flow • Business Wire • 01/12/2026 01:00:00 PM
- KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 01/05/2026 12:00:00 PM
- KORU Medical Systems Announces 510(k) Submission for Clearance of the FreedomEDGE® System with a Commercialized Oncology Biologic • Business Wire • 12/30/2025 09:05:00 PM
- KORU Medical Systems, Inc. Appoints Eric Schiller as Chief Technology Officer • Business Wire • 12/16/2025 09:05:00 PM
- KORU Medical Systems to Present Promising Results on the Use of the FreedomEDGE® Syringe Infusion System in Infusion Centers at ESID/EHA/SIOPE Focused Symposium 2025 • Business Wire • 11/17/2025 09:05:00 PM
- KORU Medical Systems to Participate in Upcoming Investor Conferences • Business Wire • 11/13/2025 01:00:00 PM
- KORU Medical Systems Announces 27% Q3 Revenue Growth and Raises 2025 Revenue Guidance • Business Wire • 11/12/2025 09:05:00 PM
- KORU Medical Systems Announces Development Agreement for Innovation in Subcutaneous Immunoglobulin Infusion Systems • Business Wire • 11/04/2025 09:05:00 PM
- KORU Medical Systems to Report Third Quarter 2025 Financial Results on November 12, 2025 • Business Wire • 10/22/2025 08:05:00 PM
- ForCast Orthopedics and KORU Medical Systems Announce Agreement for Novel Antibiotic Infusion Therapy • Business Wire • 09/18/2025 12:00:00 PM
- Cirtec Medical Announces Appointment of New Chief Executive Officer • GlobeNewswire Inc. • 08/28/2025 04:59:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/11/2025 08:26:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/11/2025 08:24:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/11/2025 08:23:25 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/11/2025 03:18:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2025 08:11:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2025 08:08:43 PM
